Something about the newer, more potent formulations, or perhaps the degree of weight loss they produce, drives the risk higher
One example is Farxiga (dapagliflozin), a brand-name drug approved to treat Type 2 diabetes and lower the risk of cardiovascular death and hospitalization in people with heart failure (when the heart is weak and cannot pump enough blood)
The science is new, and the impact of GLP-1s on bipolar disorder isnt fully known , so talk to your psychiatric prescriber first and monitor for any mood changes
These may have ingredients like berberine, cinnamon, garcinia, etc., which claim to help manage appetite, reduce insulin resistance, manage blood sugar levels and support overall wellness 9 , 10 , 12
Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by Eli Lilly could offer an intriguing off-ramp
Yacawych and his colleagues wanted to know if they could tweak these drugs to suppress appetite without making people queasy
